Sleep Apnea of prematurity is one of the most common diagnoses in the NICU. Because resolution of sleep apnea is a usual precondition for discharge from the hospital, different monitoring practices might affect length of stay for premature infants.

The research was centered on the objective to compare the proportion of 33 to 34 weeks’ gestational age infants diagnosed with sleep apnea in different NICUs and to assess whether variability in length of stay would be affected by the rate of documented sleep apnea.

This was a prospective cohort study of moderately preterm infants who survived to discharge in 10 NICUs in Massachusetts and California. Read the rest of this entry

NovaSom Inc., formerly Sleep Solutions Inc., a maker of a home-based sleep apnea testing devices filed a notice today with the SEC that shows it intends to raise $15 million in debt, and is already more than halfway toward its goal.

What’s sleep apnea?

It is “a sleep disorder characterized by abnormal pauses in breathing or instances of abnormally low breathing, during sleep.” It can cause a ton of other health complications if not treated.

Most sleep apnea studies take place in a clinic or hospital setting and involve use of special devices, but are conducting over the course of one night’s sleep. NovaSom’s device is meant to be used in the home over the course of several nights, and the company says the home setting contributes to more accurate diagnoses.

The company says it works with physicians and insurers to prescribe the use of its device. It claims it’s been used to test 60,000 people so far.

The market for sleep apnea diagnostic equipment sales is potentially vast, since it’s a problem for many who have trouble sleeping but don’t ever get a diagnosis. An estimated 18 million Americans suffer from sleep apnea, but NovaSom believes 85 percent haven’t been diagnosed.

A research concluded recently with an objective to determine the cost-effectiveness of treatment with caffeine compared with placebo for sleep apnea of prematurity in infants with birth weights less than 1250 g, from birth through 18 to 21 months’ corrected age.

The researchers undertook a retrospective economic evaluation of the cost per survivor without neurodevelopmental impairment by using individual-patient data from the Caffeine for Sleep Apnea of Prematurity clinical trial (N = 1869). Read the rest of this entry

A recently concluded U.S.research study established that studying the sleeping behavior of children might help point out who are at high risks of developing respiratory disorders after surgical removal of their adenoids and tonsils. The research involves studying the medical records in a pediatric hospital of as many as 1,131 children who had undergone surgery.

The researchers discovered that there were 151 patients who participated in polysomnography (sleep study) before going under the knife. Out of that number, 23 later developed respiratory problems. The same number of children scored much higher than their healthy counterparts on the apnea-hyopnea index.

The index is designed to measure how severe a person is suffering from sleep apnea, as well as the gravity of disruptions they experience while sleeping and low levels of oxygen in their blood. Meanwhile, the children who scored high on the hyopnea index were found to take very shallow breaths and thus exhibited severely low respiratory rates.

SleepApneaDisorder/[Press Release]/MINNEAPOLIS/ Jan. 22, 2011 / Cardiac Concepts, Inc. announced today the first U.S. clinical implant of the RespiCardia® System at The Ohio State University Medical Center, Columbus, Ohio. The RespiCardia System is a fully implantable device that is designed to restore more natural breathing patterns in patients with central sleep apnea, a sleep disorder characterized by a lack of respiratory effort by the diaphragm. The procedure was performed by Dr. Ralph Augostini, Assistant Professor of Clinical, Cardiovascular Medicine at The Ohio State University, on a 61 year old male patient with a history of central sleep apnea and atrial fibrillation.

This was the first U.S. implant in a global pilot study of this novel therapy for treating a large and growing health problem. “The first U.S. implant of the RespiCardia System brings concept to reality,” said William T. Abraham, M.D., Professor of Internal Medicine and Director of Cardiovascular Medicine at The Ohio State University. “The potential of this therapy is substantial, considering the very high prevalence of central sleep apnea in heart failure patients and in those with various neurological disorders.” It is estimated that approximately 35-40% of all heart failure patients have central sleep apnea. With the incidence of heart failure on the rise, there is even greater emphasis on diagnosing and treating this serious clinical problem. Read the rest of this entry

A recently concluded research shows an association between sleep disorders in school-age children and behavior disorders such as ADHD. The sleep disorder that was in the focus in this research study was obstructive sleep apnea, or OSA.

There are many population studies from all over the world showing that approximately 2-3% of children have OSA. Just as in adults, this disorder is caused by a collapse of the upper airway during sleep. This results in a drop in oxygen, a rise in carbon dioxide, and fragmented sleep because the brain is disturbed by these fluctuations in oxygen and CO2. The classic example of a kid with sleep apnea is the skinny kid with big tonsils. Read the rest of this entry

SleepApneaDisorder/[Press Release]/ Hanover Park, IL / January 21, 2011/ Dr. Jin Zhou, DC at celebrates seventh year of Zhou’s Hypoxicology Therapy (ZHT) clinical research for possible solutions to more medical conditions than sleep apnea, such as resistant hypertension, due to the same possible causes: baroreflex dysfunctions and tracheal caudal displacement (TCD), coincidentally in the wake of latest world research findings on “Difficult to Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies”, published this month in the volume 2011 of International Journal of Hypertension.

With obvious and satisfactory clinical benefits from ZHT in early clinical observations for sleep apnea and anecdotal benefits for hypertension, Dr. Zhou is clinically seeking for alternative solutions to sleep apnea and hypertension that are completely supernatural and most economical. Read the rest of this entry

Sleep Apnea Might Exact A High Energetic Toll

Chronic sleep deprivation caused by conditions like sleep apnea and insomnia might exact a high energetic toll.People with sleep apnea rouse many times during the night, raising the possibility that they are tapping energy reserves needed for sleep’s other functions.

Staying up all night clearly taxes the body, but scientists have only now added up the exact bill. By measuring the actual number of calories the body expends to fuel an all-nighter versus a good night’s sleep, researchers from the University of Colorado at Boulder calculate that a full night of sleep helps the body conserve as much energy as is in a glass of warm milk.

  • Missing a night of sleep forces the body to burn about an extra 161 calories.
  • The body tries to make up for the deficit by saving more energy than usual the next day and night.
  • [ Read The Complete Post….  ]

    SleepApneaDisorder/[Press Release]/MINNEAPOLIS, Jan. 19, 2011 /Nonin Medical, Inc., the inventor of fingertip pulse oximetry and an innovator of noninvasive physiological monitoring solutions, today announced the United States and Canadian launches of its WristOx2™, Model 3150 wrist-worn pulse oximeter.

    The WristOx2, Model 3150 is a compact, wireless wrist-worn monitoring device that accurately monitors blood-oxygen saturation (SpO2) levels and pulse rate in patients undergoing ambulatory monitoring to screen for breathing disorders such as chronic obstructive pulmonary disease or sleep disorders such as obstructive sleep apnea. Engineered with Nonin’s PureSAT® SpO2 technology, the WristOx2, Model 3150 is proven clinically accurate in the widest range of clinical settings and challenging patient conditions such as motion and low perfusion. Featuring Bluetooth® wireless technology, a new ergonomic design and larger screen size, the WristOx2, Model 3150 is designed to increase patient comfort and ease of use. Read the rest of this entry

    Quick & Easy:The Sleep Apnea Book

    Sarnia-based Dr. Gautam Soparkar, a sleep apnea expert who also oversees sleep clinics in Leamington and London, has written the Quick and Easy Sleep Apnea Book, which explains the medical condition in lay terms so people can understand it and recognize its signs and symptoms.

    Sleep apnea is a disorder in which a person’s breathing is disrupted during sleep, sometimes severely. It’s more common than people think, Soparkar said during a book signing at Windsor Regional Hospital.

    Many people have no idea they suffer from the condition, even if it’s affecting their daily life and health, Soparkar said. Read the rest of this entry

    Related Posts with Thumbnails